Related Experiment Video
Updated: Sep 22, 2025

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
Published on: August 11, 2018
Evolving and assembling to pierce through: Evolutionary and structural aspects of antimicrobial peptides
Sukriyo Chakraborty1, Ritika Chatterjee2, Dipshikha Chakravortty2,3
1Department of Undergraduate Studies, Indian Institute of Science, Bengaluru, India.
Antimicrobial peptides (AMPs) show promise against resistant microbes by disrupting membranes. Understanding AMP evolution and self-assembly is key to developing safer, effective therapies and overcoming clinical trial failures.
Area of Science:
- Biochemistry
- Immunology
- Evolutionary Biology
Background:
- Antimicrobial resistance (AMR) necessitates novel therapeutic strategies.
- Antimicrobial peptides (AMPs), also known as host defense peptides, are crucial components of the innate immune system.
- AMPs exhibit microbicidal activity, often through membrane permeabilization, and their self-assembly influences efficacy.
Purpose of the Study:
- To explore the evolution of AMPs.
- To elucidate the physicochemical determinants governing AMP activity.
- To review the role of AMP self-assembly in microbicidal and immunomodulatory functions.
Main Methods:
- Literature review focusing on AMP evolution.
- Analysis of physicochemical properties influencing AMP function.
- Examination of self-assembly mechanisms and their impact on activity.
Main Results:
- AMPs are integral to innate immunity and show potential against resistant pathogens.
- Peptide self-assembly is a critical factor in AMPs' microbicidal efficacy.
- Understanding evolutionary principles and physicochemical properties aids rational peptide design.
Conclusions:
- Rational engineering of AMPs, guided by evolutionary and physicochemical principles, can improve targeted antimicrobial therapies.
- Further understanding of AMP evolution and self-assembly is vital for developing safe and effective treatments.
- Addressing toxicity and hemolytic activity observed in clinical trials is crucial for AMP therapeutic success.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Transduction
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Archaeal Cell Wall
Peptidoglycan Synthesis
Structure of Porins

